Call for Operating Grant Proposals from LLSC
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s (LLSC) Operating Grant program for research aimed at preventing, detecting and treating all types of blood cancers. The application process consists of two phases. The first phase is submission and consideration of a Letter of Intent (LOI). The second phase is the invitation for and submission of a full application. The competition opens September 4, 2019. For more, see the LLSC website.
Spark Grants: Novel Technology Applications in Cancer Prevention and Early Detection
The Canadian Cancer Society, the CIHR Institute of Cancer Research, and Brain Canada Foundation have committed a total of up to $2.4M over one year to jointly fund Spark Grants at up to $150K each, focused on Novel Technology Applications in Cancer Prevention and Early Detection. The intent of this program is ... Read More »
The Canadian Cancer Society, the CIHR Institute of Cancer Research, and Brain Canada Foundation have committed a total of up to $2.4M over one year to jointly fund Spark Grants at up to $150K each, focused on Novel Technology Applications in Cancer Prevention and Early Detection. The intent of this program is ... Read More »
New Scientific Director for CIHR’s Institute of Cancer Research
Dr. Fei-Fei Liu was named Scientific Director of CIHR's Institute of Cancer Research (ICR) effective September 1, 2022. Dr. Liu has worked for more than three decades as a Clinician Scientist at the Princess Margaret Cancer Centre, where she is also the Chief of the Radiation... Read More »
Dr. Fei-Fei Liu was named Scientific Director of CIHR's Institute of Cancer Research (ICR) effective September 1, 2022. Dr. Liu has worked for more than three decades as a Clinician Scientist at the Princess Margaret Cancer Centre, where she is also the Chief of the Radiation... Read More »